From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
This two-day face to face training course helps nurses and midwives understand the public health aspects and clinical management of common STIs, HIV, hepatitis B and C. The course helps participants develop confidence in a proactive and practical approach to health care and evidence-based practice. This course is for healthcare professionals practicing in ACT. We […]
With syphilis rates continuing to rise in Australia, it is vital that healthcare workers in primary care and community settings know how to identify opportunities for syphilis testing for earlier detection and treatment. This one-hour free webinar will provide healthcare professionals with an update on the latest developments, guidelines and recommendations around syphilis testing, diagnosis, and management. Featuring clinical professionals from Melbourne Sexual Health Centre, attendees will also be given the tools to recognize typical, atypical and asymptomatic presentations of syphilis, […]
Long-Acting Reversible Contraceptives (LARC), including IUDs and contraceptive implants, are over 99% effective at preventing unintended pregnancy. Despite their efficacy, the uptake of LARC remains low in Australia. This mini clinical audit is a self-directed quality improvement activity designed to support participants to deliver evidence-based contraceptive consultations and promote the uptake of LARC among patients. A clinical audit allows health professionals to systematically review their clinical performance against best practice […]
As ASHM’s work in Papua New Guinea (PNG) continues to expand, it has become increasingly important to have somebody on the ground to lead the delivery of our health system strengthening work, with a particular focus on HIV and triple elimination. As such, this year ASHM welcomed Dr Percy Pokeya as the inaugural PNG Country Lead. Dr Pokeya will be overseeing a number of ASHM-led projects in the country, including the Supporting Triple Elimination in Papua New Guinea and Timor-Leste (STEPT) project as […]
For the first time, ASHM has published an annual Global Impact Report to highlight achievements from the previous year and to serve as an update on how key projects across Asia and the Pacific are making positive change. The report can be viewed in its entirety here, but below are some of the notable highlights […]
From November last year, the NuvaRing is listed on the Pharmaceutical Benefits Scheme (PBS), allowing Australians subsidised access to another form of contraception. The NuvaRing is a contraceptive device that is inserted into the vagina and releases a combination of oestrogen and progesterone to inhibit ovulation and increase cervical mucous preventing sperm’s ability to penetrate the uterus. It is worn for three weeks at a time, before […]
On November 1, 2025, changes to the Medicare Benefits Schedule (MBS) came into effect that are intended to significantly reduce barriers to sexual and reproductive health (SRH) in Australia. These changes will see long-acting reversible contraceptives (LARC) become more affordable and accessible for patients, particularly those in vulnerable communities who may otherwise face barriers to SRH care. These changes are informed […]
This is an Expression of Interest page. By clicking “Register Now” your name will be added to a wait list. You will be notified to register via email when a session becomes available in your state of residence or practice.
The Decision Making in Sexual and Reproductive Health: Pharmacy Consultations resource is a valuable tool designed to support pharmacists to provide evidence-based and patient-centred guidance on sexual and reproductive health (SRH) concerns. This is a quick reference tool which complements ASHM’s Fundamentals of SRH for Pharmacists training. This tool includes advice on leading SRH conversations, referral pathways, […]
The Decision Making in Gender Affirming Contraception: Consultation Essentials resource is a valuable tool designed to support clinicians to conduct gender affirming contraceptive consultations. Based on ASHM’s Decision Making in Contraception Tool this quick reference resource addresses the specific contraceptive needs of trans and gender diverse people, particularly those on hormone therapy. This resource features […]
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM